By Dr Anne Welsh, clinical psychologist, executive coach and consultant
Unlike previous generations, women in France are now more willing to speak up and take their health into their own hands
The move marks the first time the FDA has formally forced the removal of a drug
The London-based company aims to help combat late-stage cancers using proprietary technology
Around 300 women in England with HER2-negative early breast cancer will be eligible for the new drug each year
By Lorin Gu, founding partner at Recharge Capital
The new period shorts will debut on the pitch during the Women's World Cup 2023
The at-home technology aims to address key women's health areas, including fertility, contraception and endocrine conditions
By Inessa Lurye, senior director of product and head of women’s health programme at Hinge Health
Clue has extended an invite to its user community to become investors via Crowdcube
